Sterivet Laboratories Ltd said U.S. Food Drug Administration granted expedited review status proprietary drug Navicon .
The company said future marketability Navicon U.S. greatly facilitated receiving expedited review status company achieve wide penetration FDA approval drug received .
Navicon drug designed treat navicular disease affect foot one-third horse aged five 15 .
Reuter & # 3 ; 